Experience27+ Years
LevelCXO
Executive Overview
I believe in harnessing scientific innovation as a force for good in medicine—at both the individual and societal levels. At Alnylam, we have the great privilege and responsibility to advance transformative RNAi technology to ameliorate illness for many more patients as we grow and scale. Our pioneering therapeutic platform has the potential to help millions of people with rare and common diseases achieve better health outcomes.
Career Timeline
- Alnylam PharmaceuticalsCurrentOct 2014–Present· 11 yrs 11 mos
- Chief Research and Development OfficerCurrentJun 2025–Present
- Chief Medical Officer2017–Jun 2025
- SVP, Clinical DevelopmentOct 2014–2017
- Sep 2006–Oct 2014· 8 yrs 1 mo
- Vice President, Immunoscience Clinical DevelopmentAug 2011–Oct 2014
- Vice President, Full Development LeadJun 2010–Sep 2011
- Executive Director, Clinical DevelopmentSep 2006–Jun 2010
- 2001–2006· 5 yrs
- Senior Director, Clinical Development2001–2006
- 1999–2006· 7 yrs
- Attending Physician1999–2006
- 1999–2001· 2 yrs
- Instructor in Health Care Policy1999–2001
Education
Robert Wood Johnson Clinical Scholar
The Johns Hopkins University School of Medicine
Internal Medicine Residency
University of California, San Francisco
MD
Medicine
University of California, San Francisco - School of Medicine
AB
Biochemistry
University of California, BerkeleyExecutive Relationship Map
Reports To
Pushkal Garg
Vice Chair & President
Chief Financial Officer
Chief Technology Officer
Chief Operating Officer
Skills & Expertise
Regulatory AffairsMedical AffairsDrug DiscoveryBiomarkersClinical ResearchTranslational MedicineImmunologyDrug DevelopmentGCPClinical DevelopmentClinical TrialsCROTherapeutic AreasPharmaceutical IndustryBiotechnology